Top

Quality of Life Research

Gepubliceerd in:

03-04-2020 | Review

Quality of life in people with epidermolysis bullosa: a systematic review

Auteurs: C. C. G. Togo, A. P. C. Zidorio, V. S. S. Gonçalves, L. Hubbard, K. M. B. de Carvalho, E. S. Dutra

Gepubliceerd in: Quality of Life Research | Uitgave 7/2020

Abstract

Purpose

Individuals with epidermolysis bullosa (EB) present with various clinical manifestations of different severities that affect quality of life (QoL). This systematic review synthesizes the current evidence about the QoL of individuals with EB.

Methods

We included observational studies with people of all age groups, both sexes, and any EB type. Studies with qualitative methodology, chapters of books, meeting proceedings, and abstracts were excluded.

Results

In this study, 12 articles comprising 745 individuals were included. More than half of the articles observed lower QoL in individuals with recessive dystrophic EB (RDEB) or junctional EB (JEB). Three articles indicated that EB affected QoL more in women than in men, and one article identified that children with EB suffered more than adults with the disease. Pain was frequently reported. Seven articles identified difficulty in sports, two identified a need for bathing assistance, and three identified eating difficulties. Additionally, participants reported that family relationships and friendships were affected, and they experienced feelings of anxiety and depression. Some of the instruments used evaluated QoL in general dermatologic conditions, and one was specific to EB.

Conclusion

QoL is more affected in people who have RDEB and JEB. Regarding sex and age, women and children need special care in their monitoring. It is necessary that guidelines on pain management be more disseminated and put into practice. Future studies should use standardized specific instruments to assess the QoL in EB individuals, while considering the particularities of the different age groups.

volgende artikel Communicating treatment risks and benefits to cancer patients: a systematic review of communication methods

Alleen toegankelijk voor geautoriseerde gebruikers

Fine, J. D., & Mellerio, J. E. (2009). Extracutaneous manifestations and complications of inherited epidermolysis bullosa: Part I Epithelial associated tissues. Journal of American Academy of Dermatology,61(3), 367–384.CrossRef

Intong, L. R., & Murrell, D. F. (2012). Inherited epidermolysis bullosa: New diagnostic criteria and classification. Clinical Dermatology,30(1), 70–77.CrossRef

Siañez-González, C., Pezoa-Jares, R., & Salas-Alanís, J. C. (2009). Congenital epidermolysis bullosa: A review. Actas Dermo-Sifiliográficas,100(10), 842–856.CrossRef

de Oliveira, Z. N. P., Périgo, A. M., Fukumori, L. M. I., et al. (2010). Imunomapeamento nas epidermólises bolhosas hereditárias. Anais Brasileiros de Dermatologia,85(6), 856–861.CrossRef

Haynes, L. (2006). Nutritional support for children with epidermolysis bullosa. British Journal of Nursing,15(20), 1097–1101.CrossRef

Fine, J. D., Bruckner-Tuderman, L., Eady, R. A., et al. (2014). Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification. Journal of American Academy of Dermatology,70(6), 1103–1126.CrossRef

Zidorio, A. P. C., Dutra, E. S., Leao, D. O. D., et al. (2015). Nutritional aspects of children and adolescents with epidermolysis bullosa: Literature review. Anais Brasileiros de Dermatologia,90(2), 217–223.CrossRef

Sebaratnam, D. F., McMillan, J. R., Werth, V. P., et al. (2012). Quality of life in patients with bullous dermatoses. Clinical Dermatology,30(1), 103–107.CrossRef

Sebaratnam, D. F., Okawa, J., Payne, A., et al. (2015). Reliability of the Autoimmune Bullous Disease Quality of Life (ABQOL) questionnaire in the United States. Quality of Life Research,24(9), 2257–2260.CrossRef

10.

The WHOQOL Group. (1995). The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Social Science and Medicine,41(10), 1403–1409.CrossRef

11.

Both, H., Essink-Bot, M. L., Busschbach, J., et al. (2007). Critical review of generic and dermatology-specific health-related quality of life instruments. Journal of Investigative Dermatology,127(12), 2726–2739.CrossRef

12.

Frew, J. W., Martin, L. K., Nijsten, T., et al. (2009). Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: An EB-specific quality of life instrument. British Journal of Dermatology,161(6), 1323–1330.CrossRef

13.

Liberati, A., Altman, D. G., Tetzlaff, J., et al. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Medicine,6(7), e1000100.CrossRef

14.

McGowan, J., Sampson, M., Salzwedel, D. M., et al. (2016). PRESS peer review of electronic search strategies: 2015 Guideline statement. Journal of Clinical Epidemiology,75, 40–46.CrossRef

15.

Moola, S., Munn, Z., Tufanaru, C., et al. (2017). The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews Checklist for Case Series. Adelaide: The Joanna Briggs Institute.

16.

Eismann, E. A., Lucky, A. W., & Cornwall, R. (2014). Hand function and quality of life in children with epidermolysis bullosa. Pediatric Dermatology,31(2), 176–182.CrossRef

17.

Yuen, W. Y., Frew, J. W., Veerman, K., et al. (2014). Health-related quality of life in epidermolysis bullosa: Validation of the Dutch QOLEB questionnaire and assessment in the Dutch population. Acta Dermato Venereologica,94(4), 442–447.CrossRef

18.

Brun, J., Chiaverini, C., Devos, C., et al. (2017). Pain and quality of life evaluation in patients with localized epidermolysis bullosa simplex. Orphanet Journal of Rare Disease,12(1), 1–8.CrossRef

19.

Cestari, T., Prati, C., Menegon, D. B., et al. (2016). Translation, cross-cultural adaptation and validation of the Quality of Life Evaluation in Epidermolysis Bullosa instrument in Brazilian Portuguese. International Journal of Dermatology,55(2), e94–e99.CrossRef

20.

Dănescu, S., Sălăvăstru, C., Sendrea, A., et al. (2019). Correlation between disease severity and quality of life in patients with epidermolysis bullosa. Journal of European Academy of Dermatology and Venereology,33(5), e217–e219.CrossRef

21.

Horn, H. M., & Tidman, M. J. (2002). Quality of life in epidermolysis bullosa. Clinical and Experimental Dermatology,27(8), 707–710.CrossRef

22.

Jeon, I. K., On, H. R., & Kim, S. C. (2016). Quality of life and economic burden in recessive dystrophic epidermolysis bullosa. Annals of Dermatology,28(1), 6–14.CrossRef

23.

Kýrová, J., & Bučková, H. (2013). Kvalita života pacientů s epidermolysis bullosa. Czecho-Slovak Dermatology/Cesko-Slovenska Dermatologie, 88(3).

24.

Tabolli, S., Sampogna, F., Di Pietro, C., et al. (2009). Quality of life in patients with epidermolysis bullosa. British Journal of Dermatology,161(4), 869–877.CrossRef

25.

Margari, F., Lecce, P. A., Santamato, W., et al. (2010). Psychiatric symptoms and quality of life in patients affected by epidermolysis bullosa. Journal of Clinical Psychology in Medical Settings,17(4), 333–339.CrossRef

26.

Reyna, M. J. Á., González, R. M. T., & Salas-Alanís, J. C. (2016). Estrés y calidad de vida en pacientes con epidermólisis ampollar. Derma Cosmética y Quirúrgica,14(2), 112–118.

27.

Ware, J. E. Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.

28.

Finlay, A. Y., & Khan, G. (1994). Dermatology Life Quality Index (DLQI)—A simple practical measure for routine clinical use. Clinical and Experimental Dermatology,19(3), 210–216.CrossRef

29.

Lewis-Jones, M. S., & Finlay, A. Y. (1995). The Children’s Dermatology Life Quality Index (CDLQI): Initial validation and practical use. British Journal of Dermatology,132(6), 942–949.CrossRef

30.

Chren, M. M., Lasek, R. J., Quinn, L. M., et al. (1996). Skindex, a quality-of-life measure for patients with skin disease: Reliability, validity, and responsiveness. Journal of Investigative Dermatology,107(5), 707–713.CrossRef

31.

Cohen, J. S., & Biesecker, B. B. (2010). Quality of life in rare genetic conditions: A systematic review of the literature. American Journal of Medical Genetics A,152A(5), 1136–1156.CrossRef

32.

von der Lippe, C., Diesen, P. S., & Feragen, K. B. (2017). Living with a rare disorder: A systematic review of the qualitative literature. Molecular Genetics and Genomic Medicine,5(6), 758–773.CrossRef

33.

Chernyshov, P. V., Suru, A., Gedeon, I., et al. (2019). Epidermolysis bullosa-specific module of the Infants and Toddlers Dermatology Quality of Life (InToDermQoL) questionnaire. Journal of European Academy of Dermatology and Venereology,33(3), 612–617.CrossRef

34.

Schräder, N. H. B., Yuen, W. Y., & Jonkman, M. F. (2018). Pain quality assessment scale for epidermolysis bullosa. Acta Dermato Venereologica,98(3–4), 346–349.CrossRef

35.

Goldschneider, K. R., Good, J., Harrop, E., et al. (2014). Pain care for patients with epidermolysis bullosa: Best care practice guidelines. BMC Medicine,12, 178.CrossRef

36.

Pope, E., Lara-Corrales, I., Mellerio, J., et al. (2012). A consensus approach to wound care in Epidermolysis Bullosa. Journal of American Academy of Dermatology,67(5), 904–917.CrossRef

37.

Denyer, J., & Pillay, E. (2012). Best practice guidelines for skin and wound care in epidermolysis bullosa. In DEBRA: International Consensus.

38.

Haynes, L. (2007). Clinical practice guidelines for nutrition support in Infants and Children with EB. https://www.debra.org.uk/downloads/community-support/eb-clinical-practice-guidelines-nutrition-in-children-100613.pdf.

39.

Hubbard, L. D., & Mayre-Chilton, K. (2015). Quality of life among adults with epidermolysis bullosa living with a gastrostomy tube since childhood. Quality of Health Research,25(3), 310–319.CrossRef

40.

Zidorio, A. P. C., Dutra, E. S., Castro, L. C. G., et al. (2018). Gastrostomy for epidermolysis bullosa. British Journal of Dermatology,179(1), 42–49.CrossRef

41.

Fine, J. D., & Hintner, H.(2009). In J. D. Fine & H. Hintner (Eds), Life with epidermolysis bullosa (EB) etiology, diagnosis, multidisciplinary care and therapy. Wien: Springer.

42.

Fine, J. D., Johnson, L. B., Weiner, M., et al. (2004). Assessment of mobility, activities and pain in different subtypes of epidermolysis bullosa. Clinical and Experimental Dermatology,29(2), 122–127.CrossRef

43.

Dures, E., Morris, M., Gleeson, K., et al. (2011). The psychosocial impact of epidermolysis bullosa. Quality of Health Research,21(6), 771–782.CrossRef

44.

Corbin, J., & Strauss, A. (1990). Basics of qualitative research: Grounded theory procedures and techniques. Thousand Oaks, CA: Sage Publications.

Titel: Quality of life in people with epidermolysis bullosa: a systematic review
Auteurs: C. C. G. Togo
A. P. C. Zidorio
V. S. S. Gonçalves
L. Hubbard
K. M. B. de Carvalho
E. S. Dutra
Publicatiedatum: 03-04-2020
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 7/2020
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-020-02495-5

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusion

Log in om toegang te krijgen

Andere artikelen Uitgave 7/2020

Socioeconomic burden and quality of life in meningioma patients

Effect of lymphedema self-management group-based education compared with social network-based education on quality of life and fear of cancer recurrence in women with breast cancer: a randomized controlled clinical trial

Predictors of health-related quality of life among military HIV-infected individuals

Psychometric properties of a single-item visual analog scale measuring goals of care in patients with advanced cancer

Changes in quality of life and sleep across the perinatal period in women with mood disorders

Quality of life may be a more valuable prognostic factor than depression in older hemodialysis patients